Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation

The emergence of resistance to imatinib mediated by mutations in the BCR-ABL has become a major challenge in the treatment of chronic myeloid leukemia (CML). Alternative therapeutic strategies to override imatinib-resistant CML are urgently needed. In this study, we investigated the effect of AKI603...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Le-Xun, Wang, Jun-Dan, Chen, Jia-Jie, Long, Bing, Liu, Ling-Ling, Tu, Xi-Xiang, Luo, Yu, Hu, Yuan, Lin, Dong-Jun, Lu, Gui, Long, Zi-Jie, Liu, Quentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099696/
https://www.ncbi.nlm.nih.gov/pubmed/27824120
http://dx.doi.org/10.1038/srep35533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099696/
https://www.ncbi.nlm.nih.gov/pubmed/27824120
http://dx.doi.org/10.1038/srep35533

Ejemplares similares